Role of Ia antigens in graft vs. host reactions. II. Molecular and functional analysis of T cell alloreactivity by the characterization of host Ia antigens on alloactivated donor T cells by unknown
ROLE  OF  Ia  ANTIGENS  IN  GRAFT  VS.  HOST  REACTIONS 
II.  Molecular and  Functional  Analysis of T  Cell 
Alloreactivity by the Characterization  of Host 
Ia Antigens on Alloactivated  Donor T  Cells* 
By TERRY  L.  DELOVITCH,$ JOHN  F.  HARRIS,§ RENA  BATTISTELLA, AND 
KATIE KAUFMAN 
From the Bantmg and Best Department  of Medical Research,  University of Toronto, 
Toronto, Ontario, Canada M5G I L6 
The genetic and biochemical basis for the inclusion of T  cell alloreactivity within 
the  immunological  repertoire  of T  helper  (Tn) 1 lymphocytes remains  a  perplexing 
problem  (1, 2).  Recent evidence (3-9)  suggests that the ability of Tn cells to bind to 
molecular complexes formed on antigen-presenting  ceils between  a  nominal antigen 
and  either  self or  nonself  (allo)  Ia  molecules  regulates  their  different  phenotypic 
patterns  of immune  responsiveness.  This  type  of regulation  implies  that  antigen 
presentation  markedly  influences  the  TH  cell  repertoire  (t0).  It  is  likely  that  this 
repertoire is governed by the diversity and specificity of Tn cell membrane receptors 
for epitopes of the nominal antigen and either self- or allo-Ia molecules.  Because self- 
and allo-Ia molecules express not only private epitopes but also public epitopes  (11- 
13),  it  is  conceivable  that  their  TH  cell-derived  self-Ia  and  allo-Ia  complementary 
receptors  possess  some  structural  similarities  (reviewed  in  1,  14).  This  proposed 
structural  homology of different  Ia receptors  might enable a  self-Ia receptor to bind 
with high affinity to a self-Ia molecule and with lower affinity to an allo-Ia molecule; 
the reverse is expected for an allo-Ia receptor.  It is apparent,  therefore, that a  better 
understanding  of the biological  relationship  between  T  cell  self-reactivity and  allo- 
reactivity should emerge from a study of the binding capacity of alloactivated T  cells 
for self-Ia and allo-Ia molecules. 
Using immunofluorescence, we have previously shown  (15,  16)  that during a  graft 
vs. host reaction  (GVHR),  Lyt-l+2  -  donor T  cell blasts bind  detectable  amounts of 
allo-Ia molecules of host origin but not self-Ia molecules of donor origin. Host-derived 
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I-A  alloantigens  were  more  readily  transferred  to donor T  cells  than  were host  I-E 
alloantigens. These data suggested that in vivo alloactivated T  cells do not synthesize 
Ia antigens but rather acquire onto their surface Ia antigens from allogeneic antigen- 
presenting  cells,  perhaps  via  an  interaction  with  their  allo-Ia receptors.  To explore 
these possibilities,  it was of interest to extend and quantitate these observations using 
anti-/-A and anti-/-E antibodies in radioimmune cell binding assays and immunopre- 
cipitation  assays of unlabeled  and  radiolabeled  activated  donor T  cell  Ia antigens, 
respectively.  The  functional  significance  of an  intercellular  transfer  of Ia  antigens 
during  a  GVHR  posed  another  intriguing  problem.  In  particular,  we  wished  to 
determine whether different subpopulations of alloactivated donor Tn cells that were 
separated by immunofluorescence according to their capacity to bind host-derived/- 
A k alloantigens  were I-A k restricted  in their ability to elicit  antibody production  by 
either  donor  haplotype  B  cells  or  host  haplotype  B  cells.  Such  analyses  could 
conceivably bear directly on the functional relationship  of self-reactive and alloreac- 
tive TH cells. 
In this report, we demonstrate that GVHR-activated donor T  cells do not synthesize 
Ia antigens of the donor H-2 ~ haplotype but  do acquire,  in vivo, A~  k, AS  k, Ae  k, and 
E,  k Ia polypeptide chains from H-2 a host cells.  We also show that  the/-A-restricted 
helper activity of sorted subpopulations of activated  donor TH cells assayed in an in 
vitro primary antibody response correlates closely with their in vivo acquired binding 
capacity  for either  donor  (self)-  or host  (allo)-/-A  products.  This  genetic  restriction 
occurs upon interaction  with only nonimmune B cells and not with immune B cells. 
The  requirements  for  Tn  cell  self-Ia  and  allo-Ia  antigen  receptor  occupancy  are 
discussed  in  terms  of their  role  both  in  TH  cell  repertoire  development  and  B  cell 
activation.  Some  of the  data  reported  in  this  manuscript  have  been  presented  in 
preliminary form elsewhere  (17,  18). 
Materials  and Methods 
Mice.  Strains A.SW/SgSn (H-2 ~) and A/WySn (H-2 a) were purchased from The Jackson 
Laboratory, Bar Harbor, Maine.  All other strains were inbred and maintained  in oar mouse 
colony at the University of Toronto. 
Antisera.  The hyperimmune alloantisera  (A.TH ×  C3H.OL)FI anti-C3H/DiSn  (anti-Kk), 
(A.TH × B10.HTT)F1 anti-A.TL (anti-/-A k, I-Jk), B10.A(3R) anti-Bl0.A(5R) (anti-l-Jk), (B10 
x  HTI)F1 anti-B10.A(5R)  (anti-I-Ek),  A.TH anti-A.TL (anti-/k),  (BALB.B X A.AL)FI anti- 
A.TL (anti-K"), and A.TL anti-A.TH (anti-LA") were produced as previously described (19). 
F(ab')2 of rabbit anti-mouse Fab(IgG) was kindly supplied by Dr. M. Letarte (Department of 
Medical  Biophysics, University of Toronto, Canada).  Fluorescein-conjugated F(ab')2 of goat 
anti-mouse IgG was purchased from N. L. Cappel Laboratories, Cochranville, Pa. 
Hybridomas.  A303 is a hybridoma cell line that secretes  a monoclonal antibody that detects 
an Ia molecule whose a-chain (E,) is encoded by either I-E  k or LE a and whose fl chain (Ae) is 
encoded by I-A k (20). The Y17 monoclonal antibody used detects an Aek:E~  k Ia molecule (21) 
and was kindly provided by Dr. E. A. Lerner (Department of Pathology, Yale University, New 
Haven, Conn.). The anti-Ia.7 monoclonal antibody used detects an LE  molecule (22) and was 
kindly provided by Dr. U. Hammerling (Sloan Kettering Institute for Cancer Research, New 
York). The 10-2.16, 10-3.6, and  11-5.2 hybridomas, each of which secrete a monoclonal anti-/- 
A k antibody (23) and the H0.13-4 cell line, which secretes a monoclonal anti-Thy-1.2 antibody 
(24), were generously provided by Dr.  L. A.  Herzenberg  (Department  of Genetics,  Stanford 
University, Stanford, Calif.)  and Dr. M. Gefter (Department of Biology, Massachusetts Institute 
of Technology, Boston, Mass.)  to the Salk Institute Cell Distribution Center, La Jolla, Calif., 
which was our source for these  reagents.  These antibodies  were  purified  from ascites  fluids 
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Piscataway, N. J.) affinity chromatography (25). Biotinylated A303 was prepared by Dr. M. L. 
Phillips (Banting and Best Department of Medical Research, University of Toronto, Toronto, 
Canada) according to Lerner et al. (21),  and biotinylated-11-5.2 was purchased from Becton- 
Dickinson Monoclonal Antibody Center, Mountain View, Calif. 
Preparation of GVHR-alloaetivated T  Cells.  Alloactivated donor  T  eells were  obtained  as 
described (15).  Briefly, l0  s donor thymocytes from mice (4-8 wk old) were injected i.v. into 
irradiated (800 rad), H-2 congenic, and incompatible recipients (8-15 wk old) of matched sex. 
Recipient spleen cells were recovered 5 d  layer. Splenic T  cell blasts were selected by Ficoll- 
Hypaque gradient centrifugation and then panned (26) for Ig- cells using the IgG fraction of 
a polyvalent goat anti-mouse Ig serum (27) at 2.5/,g/ml to coat the panning dishes during 90 
min at 23°C. Spleen cells were panned for 70 min at 4°C. The surface-antigen phenotype of 
the nonadherent  Ig- cell fraction was determined by microeytotoxicity with either H0.13-4 
monoclonal anti-Thy-l.2 antibody or anti-K" and  •  k  •  anu-K  alloantlsera and  EDTA  agarose- 
adsorbed rabbit  complement  (C');  the  percent  of Ig-bearing cells in  this cell fraction was 
determined by immunofluorescence using fluorescein-conjugated F(ab')2 of goat  anti-mouse 
IgG and a Leitz Orthoplan fluorescent microscope (E. Leitz, Inc., Rockleigh, N. J.)  (15). 
Radioimrnune Cell-binding Assay.  The direct binding of  mouse Ig to formalin-fixed lymphocytes 
was evaluated by an indirect cell binding assay as described (20).  Formalin-fixed target cells 
(3 ×  106 to 5 ×  10  ~) were incubated with an ap,  propriate concentration range (10 -2 to 10 -5 vol/ 
vol dilution of ascites) of monoclonal anti-/-A  antibody for 15 h at 4°C in polyvinyl chloride 
(Dynatech Laboratories, Inc., Dynatech Corp., Alexandria, Va.) U-bottomed 96-well microtiter 
plates to determine the antibody concentration required to achieve saturation binding. The 
binding buffer used  was  phosphate-buffered  saline  (PBS)  containing  10%  fetal  calf serum 
(FCS), 0.1% gelatin, 10 mM Tris (pH 7.5), and 0.02% Na azide. Plates were washed three times 
and l~6I-protein A was added for  1 h  at 4°C.  After a  further three washes and drying of the 
plates, a2sI cpm bound per well was determined in a Beckman 300 gamma counter (Beckman 
Instruments Inc., Fullerton, Calif.) at 70-80% efficiency. Background binding was defined by 
the binding of 125I-protein A at each concentration of monoclonal antibody used to appropriate 
normal spleen cells and  normal thymocytes. 12~I-protein  A  was diluted before use in 0.25% 
gelatin, 10 mM Tris (pH 7.5), and 0.02%  Na azide. 
To  relate  the  observed  12~I-protein  A  specific binding  to  a  relative Ig concentration,  a 
standard titration curve was generated for each monoclonal antibody used. Serial dilutions of 
ascites of each of the monoclonal antibodies were incubated for 16 h at 4°C with acrylic plastic 
mierotiter plate wells previously coated with affinity purified F(ab')z of RAM Fab (20).  After 
2  -  -  three washes of the plate, 1 6I.protei  n A was added for 1 h at 4°C under the same conditions as 
for the cell binding assays. The results of this solid-phase binding established an  empirical 
relationship of the form y --- x  s, where y is the 125I-protein A specifically bound cpm, x is the 
relative antibody concentration, and s is the limiting slope of the binding curve, The validity 
of this method of interpreting the 125I-protein A cpm bound in cell binding assays was explored 
by evaluating the binding to suspensions containing varying amounts of expected positive and 
negative prototype splenic lymphocytes. In this manner, the ~25I-protein cpm specifically  bound 
was found to vary linearly with the ratio of positive:negative spleen cells used (J. F. Harris and 
T. L. Delovitch, manuscript in preparation). 
Radiolabeling, Immunoprecipitation, and Gel Electrophoresis.  The donor A.SW (H-2 s)  and host 
A/WySn (H-2 a) strains were used in these GVHR analyses. [SsS]Methionine-labeled, Nonidet- 
P40 (NP-40) solubilized, lentil-lectin column-bound and eluted glycoprotein-containing lysates 
of either normal spleen cells or GVHR-activated donor T  cells were prepared as previously 
described (28).  Aliquots of unlabeled, NP-40 solubilized, glycoprotein-containing lysates ob- 
tained from GVHR-activated donor T  cells were adjusted to pH 8.5  using  1 M  phosphate 
buffer,  pH 9,  and  then  labeled with  x25I using the Bolton-Hunter reagent  (1375  Ci/mmole 
specific activity; Amersham Corp., Oakville, Ontario). This was performed according to the 
method of Langone et al. (29),  with the exception that a  PBS buffer containing 0.1%  gelatin 
and  10 mM Tris-HCl, pH 7.4, was used, as reported earlier (20, 30). 
Samples (100/*1) containing ~1  X  106 to 5 ×  106 cpm were reacted with 25-50 #1 of various 
antisera for 18 h at 4°C and were further treated for 30 min at 4°C with 250 p.l of a  10% (vol/ 
vol) heat-killed, formalin-fixed suspension of Staphylococcus aureus, Cowan I strain (SaCI). The 64  ANALYSIS OF T  CELL  ALLOREACTIVITY 
pelleted SaCI were washed four times with  I  mI of PBS that contained 0.5%  NP-40,  2 mM 
methionine, and 5 mM KI. SaCI-bound proteins were eluted and electrophoresed either under 
reducing conditions for  16 h  at  10 mA on a  one-dimensional sodium dodecyl sulfate (SDS)- 
polyacrylamide (10% wt/vol) slab gel or on a two-dimensional gel according to O'Farrell (31), 
as described (30).  Gels were impregnated with EN3HANCE  (New England Nuclear, Boston, 
Mass.), dried, and then exposed to preflashed (32)  Kodak XR-1  film (Eastman  Kodak Co., 
Rochester, N. Y.)  using a Cronex Lightning Plus image-intensifying screen (Du Pont Canada 
Inc.,  Markham,  Ontario).  The  l~SI-radioactivity in  one-dimensional gel  protein  bands  was 
quantitated by scanning the autoradiograms at 520 nm with a Joyce Loebl microdensitometer 
(Joyce, Loebl & Co., Gateshead, England). Alternatively, 2-mm gel slices were cut from a one 
dimensional gel, their [35S]methionine radioactivity eluted during 16 h at 37°C into 0.5 ml of 
0.1% SDS, and then quantitated in the presence of 5 ml Aquasol (New England Nuclear) using 
a Searle Mark III liquid scintillation counter (Searle Radiographics Inc., Des Plaines, Ill.). 
Cell Sorting.  The donor A.SW (H-2 ~) and host A/WySn (H-2 ~) strains were used in these 
GVHR analyses. GVHR-activated donor (H-2 ~) T cell blasts were obtained by Ficoll-Hypaque 
centrifugation  and  panning  for  Ig- cells as  indicated above.  After washing  in  sterile PBS 
containing 5% FCS, 100 U/ml penicillin, 100 p.g/ml streptomycin, 40 #g/ml gentamycin, and 
0.02% Na azide (PBS and 5% FCS), ~30 x  106 donor T cells were pelleted and then resuspended 
in 30 #1 of biotinylated-anti-/-A  k (11-5.2,  Img IgG/ml) adjusted to about 450 #1 with PBS and 
5% FCS and incubated for 30 min at 4°C.  Cells were then centrifuged through  100% sterile, 
heat-inactivated FCS and  washed  once with  PBS  and  5%  FCS  (15),  treated with  60  ~1  of 
fluoresceinated-avidin (2.5 mg/ml, Beeton-Dickinson & Co., Rutherford, N. J.) for a further 30 
min at 4°C, and washed as above. Alternatively, in control samples, 1 ×  106 donor T cells were 
either left unstained,  stained with  only 2 /~1 of fluoresceinated-avidin, stained with  4  ~1  of 
biotinylated-anti-Aek:E,  k (A303, 0.6 mg IgG/ml) and 2/~1 of fluoresceinated-avidin, or stained 
with 10/11 of the IgG fraction (10 mg IgG/ml) of anti-/-A  s and 20/LI of fluoresceinated-F(ab')2 
of goat anti-mouse F(ab)  (0.1 mg F(ab')jml). The fluorescence and  sorting of scatter-gated 
viable cells was determined with Dr. R. O. Miller's OCI (Ontario Cancer Institute, Department 
of Medical Biophysics, University of Toronto, Toronto,  Canada)  fluorescence-activated cell 
sorter (FACS) (33). Cell suspensions to be used subsequently for tissue culture were maintained 
aseptically both before and during FACS sorting. 
Functional Assay of FACS-sorted T Cells.  GVHR-activated donor  (H-2 ~) T  cells were sorted 
with  the  FACS into subpopulations that  had  either acquired  (I-A k*)  or had  not  acquired 
(I-A ~e)  host  Ia antigens. Approximately 105 cells of each sorted T  cell subpopulation were 
cocuhured with ~4 ×  105 HO-13-4 plus C'-treated spleen cells of either donor or host origin in 
the absence or presence of I06 sheep erythrocytes (SRBC)  (batch 5 of SRBC, obtained from 
Woodlyn Laboratories, Guelph, Ontario,  was used  in  all of these experiments). T-depleted 
spleen cells were obtained from either nonimmune  mice or mice that  were immunized  5  d 
previously intraperitoneally with  0.1  ml  of a  20%  (vol/vol)  suspension  of SRBC.  Control 
cultures contained either no T  cells, unsorted activated donor T  cells, or a  mixture of equal 
numbers  (105) of I-A ks and I-Ake sorted donor T  cells to examine any mutually suppressive 
effects of these subpopulations, Triplicate cultures in 0.21  ml of RPMI  1640 medium (Grand 
Island Biological Co., Burlington, Ontario) containing 5% FCS, 4 mM glutamine, 5 x  10 -5 M 
2-mercaptoethanol,  100 U/ml penicillin, 100/~g/ml streptomycin, and 40/~g/ml gentarnycin 
were  set  up  in  flat  bottomed  Falcon  3040  Micro Test  II  96-well  microtiter plates  (Fisher 
Scientific, Don Mills, Ontario) that were maintained in a stationary form for 5 d at 37°C in a 
5%  CO2  humidified incubator. Direct  (IgM)  and  indirect  (IgG)  plaque-forming cells (PFC) 
were enumerated as before (34) using the Cunningham and Szenberg slide method (35). 
Results 
Donor T  Cell Origin of GVHR-activated Blasts.  The surface antigen phenotype of the 
panned  Ig- fraction of GVHR-activated, radioresistant, blasts was analyzed in part 
by dye exclusion microcytotoxicity and  immunofluorescence  (Table  I).  Most  of the 
Ig- blasts were shown  to be T  cells because ~95%  of these blasts were lysed by the 
HO. 13-4  monoclonal  anti-Thy-l.2  antibody  plus  C'.  Only  4%  of the  selected  Ig- DELOVITCH  ET AL.  65 
TABLE  I 
Surface Antigen Phenotype of GVHR-activated Blasts * 
Antibody  Percent 
Group  Serum treatment  specifcity  lysis~: 
1  HO.13-4  Anti-Thy-l.2  95 ztz 3 
2  Fluoresceinated  F(ab')2 of goat  Anti-IgG  4 ±  1§ 
anti-mouse IgG 
3  (BALB.B ×  A.AL)F1  anti-  Anti-K  8  93 ± 2 
A.TL 
4  (A.TH ×  C3H.OL)FI anti-  Anti-K  k  4+ 2 
C3H/DiSn 
* In this GVHR response, the donor A.SW (H-28) and host A/WySn (H-2 a) 
strains were used. 
~The values shown in groups 1, 3, and 4 are eytotoxicity indices that  are 
normalized for variations in background control lysis (5-12%). They were 
obtained in three different experiments by a dye exclusion microcytotoxlcity 
assay and  are  presented  as  the  arithmetic  SEM.  A  cytotoxic index  is 
calculated as 
percent specific lysis -  percent control lysis 
100% -  percent control lysis 
§ The value in group 2 represents the percentage of T cell blasts that  were 
stained with fluoresceinated-anti  IgG. The arithmetic SEM obtained in two 
immunofluorescence  experiments is shown. 
blasts were found by immunofluorescence  to be residual Ig-bearing cells. The T  blasts 
were further shown to have a  predominant donor origin because ~93% and 4% of the 
cells were  lysed by treatment with  C'  and anti-K  ~ (anti-donor) and anti-K  k  (anti- 
host), respectively. An approximate donor:host distribution ratio of these T  blasts is 
therefore 93:4 ffi 23:1. Such a ratio is within expectation for GVHR-activated T  blasts 
obtained from an irradiated host environment because most of the cells that home to 
and repopulate the spleen during 5 d  postirradiation (800 rad) of the host would be 
expected  to  be  of  donor  origin.  Furthermore,  we  have  not  detected  any  back- 
stimulation in an in vitro MLR response of radioresistant, host-derived, responder T 
cells by donor-derived, irradiated (3,000 rad)  stimulator spleen cells (19, 34, unpub- 
lished observations). The latter result tends to minimize any potential contribution of 
a reverse in vivo allogeneic effect to the generation of a significant number of GVHR- 
activated host-derived T  cell blasts. Thus, the data presented in Table I suggest that 
the major proportion of the GVHR-activated blasts characterized  in this study are 
donor T  cells. 
Quantitation  of Host Ia Molecules on Donor  T  Cells.  Our immunofluorescence studies 
previously demonstrated  that  host  Ia  antigens encoded  by  the  I-A  subregion but 
neither the I-J nor I-E subregion are transferred from the surface of irradiated host 
cells to the surface of GVHR-activated donor T  cells. However, they did not indicate 
(a)  the number of host I-A  molecules acquired by donor T  cells and (b)  whether the 
transfer of I-J and I-E products, and I-E products in particular, were undetectable for 
quantitative rather than qualitative reasons. Radioimmune cell-binding  assays, which 
are much more sensitive and quantitative than immunofluorescence,  were carried out, 
therefore,  to estimate the relative number of host-derived I-A  and I-E  alloantigens 
that bind to donor T  cells. 66  ANALYSIS  OF  T  CELL  ALLOREACTIVITY 
Activated  donor T  cells  were  generated  in  GVHR  responses  of either  BALB.B 
(H-2 b)  ~  BALB.K (H-2k),  BALB.K--) BALB.B,  B10  (H-2 b) --~  B10.BR  (H-2k), 
or B10.BR ~  B10 donor ~  host combinations. They were reacted  with either  the 
10-2.16 or the  10-3.6 monoclonal anti-/-A k antibody and lzSI-protein A in an indirect 
cell-binding assay.  These antibodies  bind specifically to splenic  lymphocytes of the 
1t-2 k haplotype but not the H-2 b haplotype (Table II, group 3) and thus were consid- 
ered  appropriate  to  study  the  intercellular exchange  of I-A ~ alloantigens  during  an 
H-2 b --*  H-2 k GVHR  response. 
Table  II shows that both  10-2.16 and  10-3.6 bound  specifically  (0.5-1.5%  binding) 
to  BALB.B  --*  BALB.K-  and  B10  ~  B10.BR-activated  donor  T  cells  but  not  to 
BALB.K  ~  BALB.B-  and  B10.BR  --*  B10-activated  donor  T  cells  (groups  1 and  2). 
No  significant  binding  above  control  values  (~0.1%  binding)  was  detected  in  the 
latter two combinations;  this suggests that  the Ig + cells that comprised  3-5% of these 
donor  T  cell  populations  did  not  give  rise  to  any  specific  binding.  Neither  did  any 
significant binding  occur to A.TL  (I  k)  normal  resting thymocytes  (group  3).  Because 
the  amount  of radioactivity  bound  to  unseparated  activated  spleen  cells  was  very 
similar to that  of Ig-  panned  activated  spleen cells  (groups  1 and  2),  it  is likely that 
most  if not  all  of the observed  binding  was  contributed  by  the  Ig-  T  cell  blasts  in 
TABLE  II 
Estimation  of Relative Number of Host 1-A-coded Ia Antigens  on Activated 
Donor T  Ceils * 
Group  Target cell 
Donor ~  Host 
12SI-Protein A bound:~ 
10-2.16~  10-3.6 
(anti-l-A)  (anti-/-A k) 
cpm 
BALB.B (H-2 6) --~ BALB.K (H-2  k) 
Unseparated activated spleen cells  116 -4- 28  50 4-  18 
Ig- panned activated spleen cells  160 4- 15  83 4- 8 
BALB.K ~  BALB.B 
Unseparated activated spleen cells  33 -  7  29 4-  13 
Ig- panned activated spleen cells  35 4- 9  20 4- 7 
BI0 (H-2  b) ~  B10.BR (H-2 k) 
Unseparated activated spleen cells  358 4-  136  350 4- 21 
Ig- panned activated spleen cells  394 +  36  335 4- 64 
B 10.BR --*  B10 
Unseparated activated spleen cells  54 4- 7  38 4-  13 
Ig- panned activated spleen cells  58 4-  13  36 4-  10 
BALB.K Normal spleen cells  872 4-  130  600 4- 58 
BALB.B Normal spleen cells  39 4- 5  28 4- 9 
A.TL Normal thymocytes  44 4- 11  29 4- 6 
* The binding of mouse Ig to formalin-fixed lymphocytes (5 ×  105 cells/sample) was 
evaluated as described in Materials and Methods. Mean background binding (at 
saturating levels of binding to BALB,K spleen target cells) was 41 +  22 cpm for 10- 
2.16 and 32 +  17 cpm for 10-3.6. Binding to target cells with one SD of this basal 
binding was defined as background. 
:~ Mean binding of 12~I-protein A  (2.3 ×  104 cpm =  5 ng added per sample) in cpm 
+  SE.  The lz'~I-protein A  used was labeled with the Bohon-Hunter reagent  (29). 
Five observations were made for each value. 
§ The specificity of the monoclonal 10-2.16 and 10-3.6 antibodies used is indicated in 
parentheses. See Materials and Methods for more details. DELOVITCH  ET  AL.  67 
TABLE  III 
Estimation of Relative Number of Host l-A- and 1-E-coded la Antigens on 
Activated Donor T Cells* 
Target cell 
Group  Donor ~  Host 
1251-Protein A bound:~ 
YI 7§  anti-la.7  11-5.2 
(anti-LE  ~)  (anti-LE  k)  (anti-LA k) 
~m 
1  A/SW ~  A/Wy  160 ±  36  265 ±  13  300 ±  40 
(0.04)  (0.16)  (0.03) 
2  B10--* B10.BR  236 ±  7  252 ±  11  707 ±  58 
(0.09)  (0.16)  (0.12) 
3  B10.BR-* B10.S  102±  l0  106±  10  169±  13 
(0.02)  (0.04)  (0.01) 
4  BI0 Thymus  38±8  37±7  52±8 
(0)  (0)  (0) 
5  B10.S Spleen  123 ±  36  157 ±  4  151  ±  5 
(0.02)  (O.O8)  (0.0 l) 
6  B10.BR Spleen  1270 +  34  910 ±  30  3450 ±  65 
(l.0)  (1.0)  (1.0) 
* The conditions of this experiment are the same as those in Table II except 
that J25I-protein  A  (3 ×  104 cpm =  0.45 rig) was added to each sample for  1 
h at 20°C. All cell preparations used (3 ×  105 cells/sample) were unseparated 
activated spleen cells. 
Mean binding of ~25I-protein  A  in cpm ±  SE. Four observations were made 
for each value. The figures in parentheses represent the relative number of 
cell surface bound Ig molecules. These numbers were obtained by reference 
to a  standard titration  curve of monoclonal antibody bound  to  F(ab')2 of 
RAM Fab as described in Materials and Methods. The relationship between 
~ZI-protein A cpm bound (y) and relative antibody concentration (x) deter- 
mined from the slope of this titration curve is y =  x °'T. For each monoclonal 
antibody used, the value obtained for the binding to B10.BR spleen cells was 
normalized to  1.0, and the binding to B10 thymocytes was normalized to 0. 
§ The specificity of the monoclonal Y 17, anti-Ia.7, and 11-5.2  antibodies used 
is indicated in parentheses. See Materials and Methods for more details. 
these  activated  cell  populations.  It  is  apparent,  therefore,  that  T  cells  must  be 
alloactivated to acquire the capacity to bind detectable amounts of nonself Ia antigens. 
These data confirm our immunofluorescence studies  (15)  and  provide stronger evi- 
dence  that  alloactivated  donor  T  cells  do  not  express  Ia  antigens  of  the  donor 
haplotype but do bind I-A alloantigens of the host haplotype. 
A comparison of the binding data presented in groups 1 and 2 of Table II vs. that 
of group 3  also shows  that  activated donor T  cells bind approximately one-fifth to 
one-half as many 125I-protein A  cpm when  compared to  a  normal  host  spleen  cell 
(2.6-3.8% binding).  Our previous studies suggest that a  resting B cell expresses ~ 10  4 
to  l0  s Ia molecules on its surface (J. Harris, unpublished observations). Thus, if it is 
assumed that  (a) the number of surface Ia molecules expressed is linearly related to 
the 125I-protein A cpm bound at the saturating concentration of monoclonal anti-/-A k 
used and  (b)  the kinetics used result in the binding of one protein A  molecule to one 68  ANALYSIS OF T  CELL ALLOREACTIVITY 
molecule of mouse IgG2a antibody, we estimate that between 2 X  103 and 5 X  104 host 
/-A-encoded Ia molecules may be bound by a GVHR-activated donor T  cell. Due to 
uncertainties associated with the estimation of both the number of antibody molecules 
bound  at  saturation  and  the  protein  A:antibody  stoichiometric ratio  at  any given 
point in a binding curve (Table III), the absolute number of host Ia molecules found 
on donor T  cells might be overestimated by as much as twofold to threefold. Thus, 
although  the estimated absolute number of transferred host  Ia molecules might be 
somewhat inaccurate,  the observed relative proportion of host  Ia molecules on host 
spleen cells (presumably B cells) and activated donor T  cells is quite significant. 
To determine whether the intercellular exchange of I-E alloantigens occurs during 
a GVHR response, Y17  (anti-Aek:E  k) and anti-Ia.7 (anti-/-E k) hybridoma antibodies 
were reacted in an indirect cell-binding assay to A.SW(H-2 ~)  and BI0(H-2 b) donor 
T  cells that  were activated in  response to  A/WySn(H-2  a)  and  B10.BR(H-2 k)  host 
alloantigens, respectively. These reagents bind to splenic lymphocytes of the H-2 a and 
1-1-2  k haplotypes but not to the H-2 ~ and H-2 b haplotypes (21, 22).  For comparison, 
11-5.2,  a  monoclonal anti-/-A k antibody that binds to H-2 k lymphocytes and not to 
H-2 ~ and H-2 b lymphocytes (23)  was also used. It is evident from Table III that host 
I-E products are indeed transferred to donor T  cells during a  GVHR. To relate the 
observed leVI-protein A cpm bound to a relative Ig concentration, it was necessary to 
derive an empirical relationship between these parameters.  Using this  relationship, 
the relative proportion of I-E molecules transferred (4-16%)  is about the same as the 
number of I-A  molecules transferred  (3-12%).  It is also apparent, however, that the 
relative  number of I-A k  determinants  detected  on  a  B I0.BR  spleen  lymphocyte is 
about threefold to fivefold greater than the number of I-E  k determinants. Thus, both 
I-A- and quantitatively fewer/-E-encoded host Ia molecules are transferred from host 
cells to GVHR-activated donor T  cells.  This quantitative  difference is  presumably 
the reason why the transfer of host I-E molecules was previously undetected  by the 
less sensitive immunofluorescence assay (15). 
Immunochemical Analysis" of Donor  T  Cell Ia Antigens.  To extend the cell-binding data 
presented  above,  it  was  of interest  to  analyze immunochemically whether  both  or 
perhaps only one of the  a-chain  and fl-chain  subunits  of host-derived  I-A  and  I-E 
alloantigens  are  transferred  to  donor  T  ceils.  It  was  also  of interest  to  ascertain 
whether  any  structural  alterations  of I-A  and  I-E  Ia  polypeptides  occur  during 
intercellular  transfer.  If such  a  modification(s)  in  structure  was  observed,  it  might 
provide a  better understanding  of the  role of Ia antigens  in  the genetic control  of 
lymphocyte interaction. 
Immunoprecipitates of 12~I-labeled  glycoprotein-enriched fractions of panned  Ig- 
donor T  cell blast  NP-40  lysates were analyzed under  reducing conditions  by one- 
dimensional and two-dimensional gel electrophoresis. Anti-Ia alloantisera were used 
for these experiments because they were more plentiful than the relevant monoclonal 
antibodies at the time; these two sources of antibodies yield identical gel profiles (36). 
Fig.  1 illustrates that A/WySn (H-2 a) host Ik-derived (Fig.  1 A) but not A.SW (H-2 ~) 
donor  l~-derived  (Fig.  1 D)  Ia  molecules were  precipitated  from  the  donor  T  cell 
lysates. Both Ia a-chain (31,000-34,000  tool wt) and fl-chain (28,000-31,000  rnol wt) 
polypeptides of host-derived I-A k  (Fig.  1 B)  and I-E k  (Fig.  1 C)  Ia alloantigens were 
transferred  from  host  cells  to  donor  T  cells.  Because  the  basic  Ix  invariant  chain 
(31,000  mol wt)  usually  found  in  association  with  Ia molecules  is  not  well-labeled DELOVITCH ET AL. 
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F]o.  l.  Host  (I  k) [a antigens on donor (I~)-activated T cells. One-dimensional gel fluorograms of 
immunoprecipitated t25I-labeled host A/WySn Ia antigens from activated donor A.SW T ceils. 12~I- 
labeled, glycoprotein-enriched, NP-40 lysates of A.SW-activated T cells were precleared with NMS 
and SaCI and then immunoprecipitated with either (A) A.TH anti-A.TL (anti-/k), (B) (A.TH X 
k  k  B10.HTT)F1 anti-A.TL (anti-A), (C) (BIO X HTI)F1 anti-B 10.A (5R) (anti-E), or (D) A.TL anti- 
A.TH (anti-18), using SaCI. Samples were analyzed by 10% SDS-PAGE under reducing conditions 
for 16 h at  10 mA. Microdensitometer tracings of autoradiograms of different tracks of a slab gel 
exposed by fluorography are shown. Migration positions of mol wt markers bovine serum albumin 
(68,000), IgG H-chain (55,000), ovalbumin  (43,000), porcine lactate dehydrogenase (36,000) and 
IgG L-chain (25,000) are indicated. 
with  125I (37, 38), we did not detect this polypeptide in any of the gel profiles shown 
in Fig.  1, despite the fact that we used a  gel of sufficient length  (18 cm) to permit  its 
resolution (38). It is therefore not yet known whether Ii can also undergo intercellular 
exchange  or  whether  it  is  an  integral  membrane  protein  that  cannot  be  shed  or 
secreted. 
A comparison was made of the two-dimensional gel spot patterns obtained for anti- 
I k  immunoprecipitates  of 12SI-labeled glycoprotein-containing fractions of lysates of 
normal  host  spleen  cells  (Fig.  2A)  and  activated  donor T  cells  (Fig.  2 B).  Identical 
patterns,  which revealed the presence of intact A~, AB, Ae (Eta), and E~ polypeptides 
(36) were obtained  for these samples.  This confirmed the transfer of host I-A k and I- 
E k molecules to donor T  cells, as shown in Fig.  1 above. More interestingly,  the data 
demonstrated  that  no detectable  structural  alteration  of host  Ia molecules occurred 
during  their  transfer  and  binding  to  donor T  cells,  i.e.,  they  retained  their  same 
apparent size and net charge. No Ia polypeptides were immunoprecipitated  from the 
control samples treated with either anti-I  8 (Fig. 2C)  or normal mouse serum  (NMS) 
(Fig. 2 D). 
The question of whether murine T  cells that have either not been activated or have 
been stimulated  to proliferate by either an antigen, alloantigen,  or mitogen stimulus 
synthesize  Ia  antigens  has  elicited  a  controversial  and  still  inconclusive  answer 
(reviewed  in  18,  39).  We addressed  this  question  further by examining the synthesis 
of Ia antigens  in  [35S]methionine  labeled  GVHR-activated  donor T  cells.  The one- 70  ANALYSIS  OF  T  CELL  ALLOREACTIVITY 
FIc.  2.  Two-dimensional  get  fluorograms of immunoprecipitated  125I-labeled  host  A/WySn  Ia 
antigens,  t251-1abeled, glycoprotein-enriched, NP-40  lysates were prepared from either normal A/ 
WySn (H-2";  I-A k, I-E k) spleen cells (A) or donor A.SW (H-2'; I-A s, I_E ~) GVHR-activated T  cells 
(B-D).  Precleared samples were reacted with either  (A,  B)  A.TH  anti-A.TL  (anti-/k),  (C)  A.TL 
anti-A.TH  (anti-/a),  or  (D)  NMS.  Samples  were  separated  by  isoelectric  focusing  in  the  first 
dimension (left to right)  and  by  10%  SDS-PAGE in  the second dimension (top to  bottom). The 
basic end (pH 7.5) is at the left and the acidic end (pH 4.5)  is at the right. Mol wt markers are as 
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FIO.  3.  One dimensional gel electrophoresis ofimmunoprecipitated [a'~S]methionine-labeled donor 
A.SW Ia antigens. NP-40  lysates enriched in  glycoproteins were prepared  from  [aSS]methlonine- 
labeled normal A.SW spleen cells (A, B) or GVHR-activated donor A.SW T cells (C, D). Precleared 
samples were treated with either (A, C) A.TL anti-A.TH (anti-1  +') or (B, D) A.TH anti-A.TL (anti- 
/k). The  10% SDS-slab gel was run  under reducing conditions, and the radioactivity in 2-ram gel 
slices  was  determined.  Mol  wt  markers  are  as  in  Fig.  1. DELOVITCH ET AL.  71 
dimensional  gel  profiles  presented  in  Fig.  3  clearly show  that,  in  contrast  to  the 
synthesis  of Ia  s antigens  by normal  A.SW  spleen  cells  (Fig.  3A),  activated  donor 
A.SW T  cells do not synthesize immunoprecipitable Ia  ~ antigens  (Fig.  3C).  In  the 
control samples, no synthesis of Ia  k antigens was detected by these cell populations 
(Fig.  3B and  3 D), as expected. These immunochemical data are quite compatible 
with the immunochemical and cell-binding data summarized above and the immu- 
nofluorescence data reported earlier (15). 
Note also that Ia a- and fl-chains and the Ii invariant chain were immunoprecipi- 
tated by anti-P from A.SW normal spleen cells (Fig. 3 A), These Ia polypeptides are 
presumably I-A s products because no I-E s Ia antigens are detectable by immunopre- 
cipitation  (36).  The reason for the detection of the synthesis of Ii in this experiment 
and  not  in Figs.  1 and  2 above is most  likely due to the  fact that  it can  be easily 
labeled  with  [ZSS]methionine  but  not  with  125I (38;  D.  Charron,  Department  of 
Virology and  Tumor Immunology,  Hospital  Cochin,  Paris,  France,  personal com- 
munication). 
Functional  Analysis of Donor  T Cell Subpopulations.  The studies of alloantigen binding 
to GVHR-activated donor T  cells pose several important questions with regards to 
the  functional capacity of these ceils.  First,  if the  binding of host  Ia molecules  to 
GVHR-activated  donor  Lyt-l÷2  -  T  cells  occurs  via  specific  donor  T  cell  allo-Ia 
receptors, does this postulated Ia:anti-Ia ligand:receptor type of interaction regulate 
the  helper  T  cell  activity  of these  cells  in  I-region  restricted  immune  responses? 
Second,  do  subpopulations  of GVHR  donor T  cells  exist  that  recognize only self 
(donor)-Ia or only allo (host)-Ia, and if so, do they display an H-2 preference in their 
ability to help B cells of either the donor or host haplotype, respectively? Third, does 
the repertoire of a self-Ia-reactive helper T cell overlap with that of an allo-Ia-reactive 
helper T  cell? Functional analyses of GVHR-activated donor T  cells that either bind 
or do not bind host Ia molecules were carried out in an attempt to answer some of 
these questions. 
Donor  A.SW  (H-2 ~)  ~  A/WySn  (H-2 a)  GVHR-activated  T  cell  blasts  were 
prepared  by Ficoll-Hypaque gradient  centrifugation and  panning.  Approximately 
95% of these cells were lysed with either a monoclonal anti-Thy-1.2 antibody (H0.13- 
4)  or  an  anti-K  s  serum  in  a  microcytotoxicity assay,  suggesting  that  they  were 
predominantly of donor T cell origin (Table I). In initial analytical FACS experiments, 
aliquots  (1  ×  106 cells) of this cell population were reacted first with either biotiny- 
lated-anti-/-A k (11-5.2)  or biotinylated-anti-Aek:Ea  k (A303), or both, and second with 
fluoresceinated-avidin. Alternatively, in control samples, cells were stained with either 
the IgG fraction of anti-I-A  s and  fluoresceinated-F(ab') of goat  anti-mouse IgG, or 
with  only  the  latter  reagent.  Fig.  4A  shows  that  ~20%  of the  viable  ceils  were 
specifically stained with  11-5.2 and ~ 16% of the cells were stained with A303. Only 
80% as many donor T  cells acquire host I-E alloantigens when compared with the 
number of donor T ceils that acquire host I-A alloantigens. Approximately 20% of the 
cells were stained when treated with both 11-5.2 and A303, i.e., no additive effect was 
observed. It seems, therefore, that  during this type of GVHR response, all donor T 
cells that bind host I-E molecules also bind host I-A molecules, and ~20% of the host- 
/-A-binding donor T  cells do not bind host I-E products. Only ~2-3% and 3-5% of 
the cells analyzed were found to express I-A s antigens and to be Ig  +, respectively (Fig. 
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FIG. 4.  FACS analysis  of activated  donor  A.SW T  cells.  Donor A.SW-activated T  cell  blasts 
obtained during a GVHR from the spleens  of irradiated A/WySn hosts were prepared by Ficoll- 
Hypaque gradient centrifugation and panning. Aliquots (1 ×  106 cells) of this cell population were 
then stained  (A), using fluoresceinated-avidin in the second step (  .....  ) and either biotinylated-11- 
5.2  ("  "), biotinylated-A303  (---), or biotinylated-11-5.2  plus biotinylated-A303 (----)  in the 
first step; and (B), using the IgG fraction of anti-/-A ~ and fluoresceinated-F(ab')2  of goat anti-mouse 
IgG (  ) or only the latter reagent (- - -). For each aliquot, 20,000 cells were analyzed to yield the 
profiles shown. In (C), 30 ×  106 activated A.SW donor T cell blasts were sorted after staining with 
biotinylated-11-5.2  and  fluoresceinated-avidin  (  ). Approximately 20% of the brightest  viable 
cells were taken to be I-A~; the dimmest viable cells showing no fluorescence  below channel  10 
(~66% of cells) were taken to be LA ke, Control samples  (2 X 108 cells) were treated with the IgG 
fraction of anti-l-A" and  fluoresceinated-F(ab')2  of goat anti-mouse [gG  (- --)  of left unstained 
(autofluorescence  control, • • • .). 
population  that  is highly enriched  for activated donor T  cells. 
For  the  functional  analyses,  30  ×  106  A.SW  ~  A/WySn-activated  donor  T  cell 
blasts  were  stained  with  biotinylated-ll-5.2  and  fluoresceinated-avidin  and  then 
sorted with  the  FACS  (Fig. 4 C).  The  20%  brightest  viable cells were taken  to be I- 
A k~ cells, i.e., donor T  cells that  bound  host/-A-encoded  Ia antigens.  The  dimmenst 
66% of viable cells showing no specific fluorescence were taken to be I-A ke, i.e., donor 
T  cells that  did not bind host I-A antigens. 
The  helper cell activity of I-A k~ and  I-A ke donor  T  cells for nonimrnune  T  cell- 
depleted  spleen  cells  of either  donor  or  host  origin  was  examined  in  an  in  vitro 
primary  anti-SRBC  PFC  response  (Fig.  5).  No significant responses were observed in 
the  control  cultures  in  which  T  cells were  absent  (groups  1-4).  Unsorted  activated 
donor T  cells helped in a  PFC  response  of host  B  cells but  not  donor B  cells (groups 
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Fro. 5.  H-2-restricted interaction of FACS-sorted GVHR-activated donor T cells with nonimmune 
B cells. GVHR-activated donor A.SW T cells were sorted (see Fig. 4C)  into subpopulations  that 
either bind (I-A ~) or do not bind (I-A k°) host Ia antigens. Their respective helper activities were 
assayed, with T cell-depleted spleen cells (B +  MO) obtained from either nonimmune  A.SW or 
A/WySn mice in the presence or absence of SRBC used as antigen  (Ag). Direct  (IgM) PFC are 
presented as the arithmetic SEM. Data from two experiments are shown. 
cells of the donor haplotype (groups 9-12).  I-A ~  donor T  cells that  bound host I-A 
antigens helped B  cells of only the host haplotype (groups  13-16).  Positive responses 
were  elicited  by  both  donor  and  host  haplotype-derived  B  cells  in  cultures  that 
contained both I-A ke and I-A ~  donor T  cells (groups  17-20).  No suppressive effect 
was evident, therefore,  upon  mixing these two subpopulations of donor T  cells, yet 
donor B cells were unresponsive when interacted with unsorted donor T  cells (groups 
5 and 6). Although the reason for the latter result is not understood, it is possible that 
some donor haplotype-specific suppressor T  cells were deleted from the selected sorted 
T  cell subpopulations. In addition, it is likely that in the unsorted activated donor T 
cell population the precursor frequency of allo (host)-reactive T  cells is much greater 
than  that  of self (donor)-reactive  helper  T  cells.  This  might  also  account  for  the 
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F1o.  6.  H-2-nonrestricted interaction of FACS-sorted GVHR-activated donor T cells with immune 
B ceils. The I-A t~ and LA ke subpopulations of donor T  cells  were separated as in Fig.  4C. Their 
helper activities for T  cell-depleted spleen cells obtained from A.SW and A/WySn mice previously 
immunized with SRBC were assayed. Indirect  (IgG)  PFC are presented as the  arithmetic  SEM. 
Direct PFC (~200) have been subtracted. Data from two experiments are shown. 
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When the helper activity of  LAke  and I-A u9 donor T cells for T cell-depleted spleen 
cells obtained from SRBC-immunized mice was examined, each T  cell subpopulation 
cooperated with  antigen-primed  B  cells of the  donor and  host  haplotypes  (Fig.  6, 
groups 9-16). A similar finding was noted for the helper activity of unsorted donor T 
cells  (groups  5-8).  Again,  no  suppressor  T  cell  activity  was  observed  in  cultures 
containing a mixture of the I-A ke and I-A ~  donor T  cell subpopulations (groups 17- 
20). Thus, whereas specific recognition of Ia antigens is required for an interaction 
between GVHR-activated donor T  helper cells and  nonimmune B  cells during an 
IgM PFC response (Fig. 5), no I-region restricted interactions occur between alloac- 
tivated donor T  helper cells and immune B cells during an IgG PFC response (Fig. 6). 76  ANALYSIS OF T  CELL ALLOREACTIVITY 
Discussion 
To  further  unravel  the  enigma  of  the  genetic  and  molecular  basis  of  T  cell 
alloreactivity, a  biochemical and biological analysis of GVHR-activated T  lympho- 
cytes was carried out. In particular, the Ia antigen phenotype and the helper activity 
of alloactivated  donor  T  cell  subpopulations  in  /-region-restricted  responses  were 
analyzed.  Immature donor T  lymphocytes, i.e,, thymocytes, were used as the source 
of T  cells in these studies so that their acquisition of alloreactivity could be examined 
in vivo during differentiation in an allogeneic host environment. 
Both  radioimmune  cell-binding  and  immunoprecipitation  assays  demonstrated 
that  alloactivated  donor  T  lymphocytes  do  not  express  detectable  amounts  of ta 
antigens of the donor haplotype but do bind readily detectable amounts of I-A- and 
/-E-encoded Ia antigens of the host haplotype. Interestingly, about three to five times 
more host  I-A  alloantigens  than  I-E alloantigens  are acquired  by donor T  cells.  As 
many as  2  ×  10  a and  perhaps  even  as  great  as  5  ×  104  host  I-A  molecules  were 
estimated  to be transferred  to  the surface of an  activated  donor T  cell  blast.  This 
suggests that between  103 and  104 host I-E molecules may be bound by a donor T  cell 
blast.  Because  it  is  likely  that  host  Ia  molecules  bind  to  a  donor  T  cell  via  an 
interaction with its Ia alloantigen receptors, it is intriguing to speculate whether the 
estimated number of host Ia molecules bound to an activated donor T  cell reflects the 
expression of an equivalent number of Ia-receptor molecules present on such a cell. If 
it is assumed that one and only one Ia molecule can bind to its complementary T  cell 
Ia receptor, then an alloreactive T  cell might express between  10  a and 5 X  104 allo-Ia 
receptors  on  its  surface.  It  should  be  recognized  that  the  estimated  numbers  of 
transferred Ia molecules and allo-Ia receptors on alloactivated T cells presented above 
serve only to identify the range of sensitivity of detection of our assays and might not 
reflect the absolute number of these molecules expressed on the surface of an activated 
T  cell for reasons stated earlier (see Results). 
The finding that fewer I-E- than/-A-encoded  host Ia molecules are transferred to 
donor T  cells is consistent with our immunofluorescent data, which indicate that there 
exist  two  subpopulations  of host  Ia-binding  donor  T  cell  blasts  (Fig.  4A).  One 
subpopulation binds both host I-A and I-E products; the second subpopulation binds 
only host I-A products; thus, the percentage of donor allo-l-A-binding T cells is greater 
than  the  percentage  of donor  allo-I-E-binding  T  cells.  These  observations  might 
explain those reported in  previous  (40-43)  functional  analyses of GVHR  responses, 
which  showed  that  an  I-A  incompatibility induces  a  much  stronger  response  than 
that  obtained  in  an I-E incompatibility.  They are also compatible with  the results 
that the rate of shedding and/or secretion ofI-A alloantigens from spleen cells is about 
fivefold  greater than  that  of I-E alloantigens  (R.  Cone,  Department  of Pathology, 
Yale University, personal communication).  Finally,  they agree with the notion  that 
both I-A- and/-E-encoded Ia molecules mediate antigen presentation to T  cells (6, 7). 
Because  the  recognition  of only syngeneic I-E antigens  is  sufficient  to elicit  T  cell 
proliferative responses to certain  antigens  under  two Ir gene control,  by analogy it 
will prove interesting in the future to determine whether a subpopulation of GVHR- 
activated donor T  cells that binds only host allo-I-E antigens can be identified. 
It  has been  amply documented  that  different  subpopulations  of mouse,  human, 
and guinea pig T  cells possess either an Ia- or Ia  + surface antigen  phenotype.  The 
question  of whether  Ia  +  T  cells  synthesize  the  Ia  molecules  that  appear  on  their DELOVITCH ET AL.  77 
surface has,  however, been a  controversial issue.  Only a  limited  number of direct 
biosynthesis studies  have been carried out  to address  this  question.  Whereas some 
reports have suggested that  nonactivated thymocytes and  peripheral T  cells of the 
mouse synthesize Ia antigens (44, 45), other reports have shown this definitely not to 
be  the  case  (46,  47).  Conflicting data  related  to  the  expression  of Ia  antigens  by 
activated T  cells has also been published.  In one instance  (48), the synthesis of Ia 
antigens by human MLR-activated responder T  lymphocytes has been convincingly 
shown;  in  other  instances  (49)  it  is  purported  that  an  intercellular  transfer  of Ia 
antigens from antigen-presenting cells to responding T  cells can account for a  large 
extent of the Ia  + phenotype of the two types of human T  cells implicated in either 
various  disease  states  or  in  mitogen,  antigen,  and  alloantigen  stimulation.  In  the 
mouse, numerous examples of this type of intercellular transfer of Ia antigens have 
been  found.  About  20%  of GVHR  donor T  cell blasts  (Fig.  4),  and  in  other H-2 
incompatibilities  as  many  as  30-50%  of donor T  cell  blasts  (15),  acquire  an  Ia  + 
phenotype by their ability to bind allo-Ia molecules presumably produced by host 
macrophages and/or B cells. Both of the latter cell types synthesize Ia antigens  (46). 
Our  biosynthetic studies  in  this  report demonstrate  that  murine  GVHR-activated 
donor T  helper cells do not synthesize Ia antigens (Fig. 3). Similarly, it is known that 
-30-50% of MLR-activated murine responder T cells can acquire either allogeneic or 
syngeneic stimulator cell-derived Ia antigens onto their surface (50, 51). Recently, it 
has also been shown in radiation-induced bone marrow-derived chimeric mice that 
-20%  of donor  bone  marrow-derived  thymocytes bind  host  Ia  antigens  on  their 
surface as they mature in the host thymic environment (52).  T  helper cells can also 
adsorb  macrophage-derived  syngeneic Ia  antigens  onto  their  surface  (53-55);  this 
adsorption is mediated by ~20% of immune T  helper cells, is antigen-specific, and is 
dependent on the presence ofI-A + antigen-presenting macrophages (54). The reason(s) 
for the discrepancy in the proof of synthesis, or lack thereof, of Ia antigens by different 
T cell subsets remains unknown. Nevertheless, in the several cases ofT cell acquisition 
of Ia antigens cited, it is probable that an intercellular exchange of Ia molecules is 
mediated by the binding of Ia molecules to specific Ia antigen T  cell receptors, as 
discussed above. It is interesting to note that  both Ia a- and fl-polypeptides can be 
transferred to T cells in an apparently intact, nonprocessed and structurally unaltered 
form (Figs.  1 and 2). This might result from the fact that Ia molecules are constitutively 
synthesized under physiological conditions, and, therefore, they need not be processed, 
as does a nominal antigen, before binding to T  cells. 
The  notion  of complementarity  between  cell  surface  antigens  and  cell  surface 
receptors of interacting networks of lymphocytes is currently of prime importance 
(56). It  follows that  the phenomenon of Ia intercellular exchange described in  this 
report might reflect the binding specificity of certain T cell subsets for syngeneic and/ 
or allogeneic Ia antigens and control their respective repertoires in/-region-restricted 
responses via complementary anti-Ia:Ia  interactions. That this is indeed the case is 
suggested  by  our  functional  analyses,  which  showed  that  the  Ia  antigen-binding 
specificity of the I-A ke and I-A k~ subpopulations of GVHR-activated donor T  cells 
regulates their/-region-restricted helper activity in a primary antibody response (Fig. 
5). This specificity might be mediated by allo-/-A and self-/-A receptors that  could 
conceivably represent different molecules on distinct T cell subsets. From these studies 
and those of others on T  helper cells obtained from chimeric mice (reviewed in 5, 8, 78  ANALYSIS OF  T  CELL  ALLOREACTIVITY 
9,  57),  it is evident that  the phenotype of H-2 restriction is not determined by the 
H-2 genotype of T  helper cells. 
As an alternative hypothesis, allo-Ia and self-Ia receptor molecules may be func- 
tionally distinguishable yet structurally homologous, or even identical. It is possible 
that such an alloreactive T  cell receptor can bind to allo-Ia with high affinity and to 
self-Ia  with  lower affinity;  our  studies  (18,  30)  on  the  alloreactive,  Ia--  and  I-A- 
restricted component of allogeneic effect factor (AEF), a likely candidate for a T  cell 
Ia alloantigen receptor, are compatible with this notion. Thus, it remains to determine 
whether the self-reactive/-A ~e donor T  cells characterized here can also help B cells 
of a  haplotype that  differs from the host haplotype used.  Several T  cell clones that 
proliferate  in  response  to  both  self-Ia  plus  antigen  and  allo-Ia  in  the  absence  of 
antigen have been identified (5-7, 58). It is not known whether allospecific T  helper 
cells recognized allo-Ia antigens independently or allo-Ia antigens in association with 
other cell surface antigens.  The frequency observed thus far for such heteroclitic T 
cell clones is ~5% of that observed for T  cell clones that are only self-reactive. Further 
genetic and biochemical experimentation with GVHR-induced alloreactive T  helper 
cell  clones  of either  self-/-A  and/or  allo-/-A  specificity  is  required  to  resolve  the 
structural  relationship between self-Ia and allo-Ia T  cell receptors. It is anticipated 
that such studies, together with those on the/-A restricted helper component of AEF, 
will further clarify the biological significance of alloreactivity. 
Finally, although alloactivated donor T  cells collaborate with nonimmune B cells 
in an/-region-restricted in vitro primary response  (Fig. 5), no/-region restriction is 
necessary for the interaction of these donor T  cells with immune B cells in an in vitro 
secondary response (Fig. 6). These observations directly confirm those of Melchers et 
al.  (59),  who  demonstrated  that  /-region-restricted  immune  responses  occur  with 
small, resting, antigen-unprimed B cells but not with large, dividing, antigen-primed 
and/or LPS-primed B cell blasts. Very similar findings have been obtained with the 
68,000 mol wt,/-A-restricted component of AEF (18)  and a  70,000 mol wt, antigen- 
nonspecific but  /-A-restricted component of an  SRBC-specific cloned T  helper cell 
line (60);  both of these T  cell products are I-region restricted in their helper activity 
for nondividing unprimed  B  cells but  not  for dividing primed  B  cell blasts.  Thus, 
once B  cells  have  been  stimulated  to  divide  by either  an  antigenic  or  mitogenic 
stimulus, recognition of their surface Ia antigens by cooperating T  cells and macro- 
phages apparently is no longer required for effective interaction. 
Summary 
Graft vs. host response (GVHR)-activated donor T  cells bind to stimulatory host 
cell-derived Ia antigens. Radioimmune cell-binding assays demonstrate that activated 
donor T  cells acquire both host I-A  and/-E alloan'tigens on their surface. Approxi- 
mately  threefold  to  fivefold  less  I-E  products  than  I-A  products  are  transferred. 
Immunoprecipitation and one-dimensional and  two-dimensional gel electrophoresis 
analyses show that radioiodinated a  and fl polypeptide chains of both I-A- and ~-E- 
encoded host Ia molecules may be transferred in an apparently structurally unaltered 
form from host cells to donor cells.  Biosynthetic studies indicate that [35S]methionine- 
labeled activated donor T  cells do not synthesize Ia antigens of the donor haplotype. 
Functional analyses with  fluorescence-activated cell sorter s~rted  donor T  cell sub- 
populations  show  that  donor  T  cells  that  bind  host  I-A  antigens  preferentially DELOVITCH ET AL.  79 
cooperate with  nonimmune  host  B  cells.  Donor T  cells that  do not  bind  detectable 
amounts  of host  I-A  antigens  preferentially  help  nonimmune  donor  B  cells.  By 
contrast,  donor T  cells that  either bind or do not bind  host I-A  antigens  display no 
H-2-restricted interaction  and help both donor and host immune B cells. These data 
reveal that the Ia antigen-binding specificity of distinct  functional subpopulations of 
alloactivated  donor  T  cells  regulates  their  /-region-restricted  (self  or  allo)  helper 
activity for nonimmune  B  cells  but  not  immune  B  cells.  Furthermore,  they suggest 
that T  cell-maerophage and T  cell-B cell collaboration is mediated by a complemen- 
tary anti-Ia:Ia receptor:ligand  type of interaction  in which  the  receptor of a  T  cell 
binds to the ligand of an antigen-presenting  macrophage and/or B cell. 
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